Adenosine monophosphate-activated
protein kinase (AMPK) plays pivotal roles in
metabolic diseases including
type 2 diabetes. However, the specific role of AMPK for
orthodontic tooth movement in
type 2 diabetes is unclear. In this study, a diabetic rat model was established through dietary manipulation and
streptozocin injection. Examinations were conducted to select qualified type 2 diabetic rats. Then, an orthodontic device was applied to these rats for 0, 3, 7, or 14 days. The distance of
orthodontic tooth movement and parameters of alveolar bone were analyzed by micro-computed tomography. Periodontal osteoclastic activity, inflammatory status, and AMPK activity were measured via histological analyses. Next, we repeated the establishment of diabetic rats to investigate whether change of AMPK activity was associated with
orthodontic tooth movement under
type 2 diabetes. The results showed that diabetic rats exhibited an exacerbated alveolar
bone resorption, overactive
inflammation, and decreased periodontal AMPK activity during
orthodontic tooth movement. Injection of the AMPK agonist alleviated
type 2 diabetes-induced periodontal
inflammation and alveolar
bone resorption, thus normalizing distance of
orthodontic tooth movement. Our study indicates that
type 2 diabetes decreases periodontal AMPK activity, leading to excessive
inflammation elevating osteoclast formation and alveolar
bone resorption, which could be reversed by AMPK activation.